However, the severity of colitis in TSA-treated Prkar2a−/− mice was still milder than that in WT mice (Fig. 8b–e), suggesting that ISGs inhibition cannot completely reverse the resistance to DSS-induced colitis in Prkar2a−/− mice. The gene discussed is PRKAR2A; the disease is colitis.